Fig. 3From: Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivoAssessment of DNA damage by flow cytometry. HNE-1 cells were cultured with evofosfamide for 24 h at the indicated concentration under hypoxia or normoxiaBack to article page